Pragmatic Trials with Design Considerations for Cardiovascular Outcome Trials

Mapping Intimacies ◽

10.1201/9780429488801-13 ◽

2021 ◽

pp. 215-232

Author(s):

Li-An Lin ◽

Ed Whalen ◽

Melvin Munsaka ◽

William Wang

Keyword(s):

Cardiovascular Outcome ◽

Pragmatic Trials ◽

Cardiovascular Outcome Trials ◽

Design Considerations

Download Full-text

Identification of Subpopulations Exhibiting the Greatest Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide-1 Receptor Agonists—A Combined Analysis of Large Cardiovascular Outcome Trials

Diabetes ◽

10.2337/db18-1064-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1064-P

Author(s):

YU MI KANG ◽

YUN KYUNG CHO ◽

JONG HAN CHOI ◽

CHANGYUN WOO ◽

WOO JE LEE ◽

...

Keyword(s):

Cardiovascular Outcome ◽

Combined Analysis ◽

Cardiovascular Outcome Trials ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting ◽

Cardiovascular Benefit

Download Full-text

Faculty Opinions recommendation of SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734434782.793555944 ◽

2019 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Secondary Prevention ◽

Meta Analysis ◽

Sglt2 Inhibitors ◽

Cardiovascular Outcome ◽

Primary And Secondary Prevention ◽

Cardiovascular Outcome Trials ◽

Download Full-text

Updates on cardiovascular outcome trials in diabetes

Cardiovascular Diabetology ◽

10.1186/s12933-017-0610-y ◽

2017 ◽

Vol 16 (1) ◽

Author(s):

Oliver Schnell ◽

◽

Lars Rydén ◽

Eberhard Standl ◽

Antonio Ceriello

Keyword(s):

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A Meta-analysis of Cardiovascular Outcome Trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2021.108648 ◽

2021 ◽

pp. 108648

Author(s):

Awadhesh Kumar Singh ◽

Ritu Singh

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Statistical Considerations for Cardiovascular Outcome Trials in Patients with Type 2 Diabetes Mellitus

Statistics in Biopharmaceutical Research ◽

10.1080/19466315.2017.1280411 ◽

2017 ◽

Vol 9 (4) ◽

pp. 347-360 ◽

Author(s):

Olga Marchenko ◽

Qi Jiang ◽

Christy Chuang-Stein ◽

Cyrus Mehta ◽

Mark Levenson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon‐like peptide‐1 receptor agonists

Diabetes Obesity and Metabolism ◽

10.1111/dom.13962 ◽

2020 ◽

Vol 22 (5) ◽

pp. 817-827 ◽

Author(s):

Veronica Sciannameo ◽

Paola Berchialla ◽

Emanuela Orsi ◽

Olga Lamacchia ◽

Susanna Morano ◽

...

Keyword(s):

Clinical Practice ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitor and Its Possible Cardioprotective Mechanism

Journal of Lipid and Atherosclerosis ◽

10.12997/jla.2018.7.1.21 ◽

2018 ◽

Vol 7 (1) ◽

pp. 21

Author(s):

Yongin Cho ◽

Eun Seok Kang

Keyword(s):

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Sodium Glucose Cotransporter

Download Full-text

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

Diabetes & Metabolism Journal ◽

10.4093/dmj.2018.0070 ◽

2019 ◽

Vol 43 (4) ◽

pp. 410 ◽

Author(s):

Yu Mi Kang ◽

Yun Kyung Cho ◽

Jiwoo Lee ◽

Seung Eun Lee ◽

Woo Je Lee ◽

...

Keyword(s):

Meta Analysis ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting ◽

Cardiovascular Benefit

Download Full-text

Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials

Journal of Diabetes ◽

10.1111/1753-0407.13007 ◽

2019 ◽

Vol 12 (4) ◽

pp. 279-293 ◽

Author(s):

José Silva‐Cardoso ◽

Omar Sheikh ◽

Mouhamed Nashawi ◽

Son Pham ◽

Kelly M. Gallegos ◽

...

Keyword(s):

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text

Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”

10.1159/000507361 ◽

2020 ◽

Vol 145 (6) ◽

pp. 387-387

Author(s):

Pierre Ambrosi ◽

Aurélie Daumas ◽

Patrick Villani ◽

Roch Giorgi

Keyword(s):

Cardiovascular Events ◽

Glycosylated Hemoglobin ◽

Antidiabetic Drugs ◽

Cardiovascular Outcome ◽

Cardiovascular Outcome Trials

Download Full-text